Pulmonary function in diabetes a metaanalysis

Chest

Volumn 138, Issue 2, 2010, Pages 393-406

  Van Den Borst, Bram ^a   Gosker, Harry R ^a   Zeegers, Maurice P ^b,c   Schols, Annemie M W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ARTICLE; ASTHMA; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION; LUNG FUNCTION; PRIORITY JOURNAL; SMOKING; SYSTEMATIC REVIEW;

EID: 77955386489     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-2622     Document Type: Article

References (74)

1. World Health Organization. Fact sheet: diabetes. No.312, November 2008. http://www.who.int/mediacentre/factsheets/fs312/en/index.html. Accessed April 14, 2009.
2. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328(23):1676-1685.
3. Ceglia L, Lau J, Pittas AG. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus. Ann Intern Med. 2006;145(9):665-675. (Pubitemid 46768843)
4. Rosenstock J, Cefalu WT, Hollander PA, et al. Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes. Diabetes Care. 2008;31(9):1723-1728.
5. Rosenstock J, Bergenstal R, Defronzo RA, et al;0008 Study Group. Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulinnaive type 2 diabetes suboptimally controlled with oral agents. Diabetes Care. 2008;31(11):2177-2182.
6. Kuitert LM. The lung in diabetes - yet another target organ? Chron Respir Dis. 2008;5(2):67-68.
7. Hsia CC, Raskin P. Lung involvement in diabetes:does it matter? Diabetes Care. 2008;31(4):828-829.
8. Teeter JG, Riese RJ. Cross-sectional and prospective study of lung function in adults with type 2 diabetes:the Atherosclerosis Risk in Communities (ARIC) study:response to Yeh et al. Diabetes Care. 2008;31(10):e82.
9. Kaparianos A, Argyropoulou E, Sampsonas F, Karkoulias K, Tsiamita M, Spiropoulos K. Pulmonary complications in diabetes mellitus. Chron Respir Dis. 2008;5(2):101-108.
10. Hsia CC, Raskin P. Lung function changes related to diabetes mellitus. Diabetes Technol Ther. 2007;9(Suppl 1):S73-S82.
11. Sandler M. Is the lung a 'target organ' in diabetes mellitus? Arch Intern Med. 1990;150(7):1385-1388.
12. Ardigo D, Valtuena S, Zavaroni I, Baroni MC, Delsignore R. Pulmonary complications in diabetes mellitus:the role of glycemic control. Curr Drug Targets Inflamm Allergy. 2004;3(4):455-458.
13. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology:a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012.
14. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-968.
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634. (Pubitemid 27387172)
17. Cazzato S, Bernardi F, Salardi S, et al. Lung function in children with diabetes mellitus. Pediatr Pulmonol. 2004;37(1):17-23. (Pubitemid 38030065)
18. Scano G, Filippelli M, Romagnoli I, et al. Hypoxic and hypercapnic breathlessness in patients with type I diabetes mellitus. Chest. 2000;117(4):960-967. (Pubitemid 30228349)
19. Fuso L, Cotroneo P, Basso S, et al. Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus. Chest. 1996;110(4):1009-1013. (Pubitemid 26347619)
20. Boulbou MS, Gourgoulianis KI, Klisiaris VK, Tsikrikas TS, Stathakis NE, Molyvdas PA. Diabetes mellitus and lung function. Med Princ Pract. 2003;12(2):87-91.
21. Boulbou MS, Gourgoulianis KI, Petinaki EA, Klisiaris VK, Maniatis AN, Molyvdas PA. Pulmonary function and circulating adhesion molecules in patients with diabetes mellitus. Can Respir J. 2003;10(5):259-264. (Pubitemid 37192987)
22. Maiolo C, Mohamed EI, Andreoli A, Candeloro N, Rossi P, De Lorenzo A. Is altered body fat distribution responsible for reduced pulmonary function in obese type 2 diabetic adult women? Diabetes Care. 2001;24(5):961-962.
23. Kabitz HJ, Sonntag F, Walker D, et al. Diabetic polyneuropathy is associated with respiratory muscle impairment in type 2 diabetes. Diabetologia. 2008;51(1):191-197.
24. El-Jundi H, Dagdelen S, Demir AU, et al. Insulin therapy preserves pulmonary diffusing capacity [abstract]. ERS; 2005.
25. McKeever TM, Weston PJ, Hubbard R, Fogarty A. Lung function and glucose metabolism: an analysis of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2005;161(6):546-556. (Pubitemid 40349910)
26. Lange P, Groth S, Kastrup J, et al. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Respir J. 1989;2(1):14-19.
27. Tantucci C, Scionti L, Bottini P, et al. Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients. Chest. 1997;112(1):145-153.
28. Tantucci C, Bottini P, Fiorani C, et al. Cerebrovascular reactivity and hypercapnic respiratory drive in diabetic autonomic neuropathy. J Appl Physiol. 2001;90(3):889-896.
29. Chance WW, Rhee C, Dane DM, et al. Impaired pulmonary function in patients with type-2 diabetes mellitus [abstract]. Proc Am Thorac Soc. 2006;3:A721.
30. Niranjan V, McBrayer DG, Ramirez LC, Raskin P, Hsia CC. Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am J Med. 1997;103(6):504-513. (Pubitemid 28018653)
31. Chance WW, Rhee C, Yilmaz C, et al. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care. 2008;31(8):1596-1601.
32. Benbassat CA, Stern E, Kramer M, Lebzelter J, Blum I, Fink G. Pulmonary function in patients with diabetes mellitus. Am J Med Sci. 2001;322(3):127-132.
33. Schuyler MR, Niewoehner DE, Inkley SR, Kohn R. Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir Dis. 1976;113(1):37-41.
34. Sandler M, Bunn AE, Stewart RI. Pulmonary function in young insulin-dependent diabetic subjects. Chest. 1986;90(5):670-675. (Pubitemid 17181634)
35. Sandler M, Bunn AE, Stewart RI. Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis. 1987;135(1):223-229.
36. Primhak RA, Whincup G, Tsanakas JN, Milner RD. Reduced vital capacity in insulin-dependent diabetes. Diabetes. 1987;36(3):324-326. (Pubitemid 18028424)
37. Baraldi E, Monciotti C, Filippone M, et al. Gas exchange during exercise in diabetic children. Pediatr Pulmonol. 1992;13(3):155-160.
38. Strojek K, Ziora D, Sroczy ski JW, Oklek K. Pulmonary complications of type 1 (insulin-dependent) diabetic patients. Diabetologia. 1992;35(12):1173- 1176.
39. Quatraro A, Minei A, Consoli G, De Rosa N, Acampora R, Giugliano D. Respiratory function in IDDM patients. Diabetes Care. 1993;16(5):851-852.
40. Innocenti F, Fabbri A, Anichini R, et al. Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract. 1994;25(3):161-168.
41. Schnack C, Festa A, Schwarzmaier-D'AssiéA, Haber P, Schernthaner G. Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy. Nephron. 1996;74(2):395-400. (Pubitemid 26326716)
42. Pieron M, Scheen AJ, Corhay JL, Radermecker MF, Lefebvre PJ. Bronchial reactivity in diabetic patients [in French]. Rev Mal Respir. 1997;14(5):379-385.
43. Makkar P, Gandhi M, Agrawal RP, Sabir M, Kothari RP. Ventilatory pulmonary function tests in type 1 diabetes mellitus. J Assoc Physicians India. 2000;48(10):962-966.
44. Villa MP, Montesano M, Barreto M, et al. Diffusing capacity for carbon monoxide in children with type 1 diabetes. Diabetologia. 2004;47(11):1931-1935.
45. Isotani H, Nakamura Y, Kameoka K, et al. Pulmonary diffusing capacity, serum angiotensin-converting enzyme activity and the angiotensin-converting enzyme gene in Japanese noninsulin-dependent diabetes mellitus patients. Diabetes Res Clin Pract. 1999;43(3):173-177.
46. Guazzi M, Brambilla R, De Vita S, Guazzi MD. Diabetes worsens pulmonary diffusion in heart failure, and insulin counteracts this effect. Am J Respir Crit Care Med. 2002;166(7):978-982.
47. Lau AC, Lo MK, Leung GT, Choi FP, Yam LY, Wasserman K. Altered exercise gas exchange as related to microalbuminuria in type 2 diabetic patients. Chest. 2004;125(4):1292-1298. (Pubitemid 38501341)
48. Sinha S, Guleria R, Misra A, Pandey RM, Yadav R, Tiwari S. Pulmonary functions in patients with type 2 diabetes mellitus &correlation with anthropometry µvascular complications. Indian J Med Res. 2004;119(2):66-71. (Pubitemid 38344478)
49. Yu HY, Zhang Y, Huimin B. Pulmonary function in type 2 diabetes and its related factors [in Chinese]. Med J Wuhan Univ. 2004;25(5):552-553,556.
50. Weisbrod CJ, Eastwood PR, O'Driscoll G, Green DJ. Abnormal ventilatory responses to hypoxia in type 2 diabetes. Diabet Med. 2005;22(5):563-568.
51. 99mTc-DTPA aerosol scintigraphy and carbon monoxide diffusion capacity. J Diabetes Complications. 2006;20(4):205-209.
52. Ortíz-Aguirre AR, Vargas MH, Torres-Cruz A, Quijano-Torres M. Age related spirometric changes in diabetic patients [in Spanish]. Rev Invest Clin. 2006;58(2):109-118.
53. Yeh HC, Punjabi NM, Wang NY, et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care. 2008;31(4):741-746.
54. Cooper BG, Taylor R, Alberti KG, Gibson GJ. Lung function in patients with diabetes mellitus. Respir Med. 1990;84(3):235-239. (Pubitemid 20223476)
55. Tan MQ, Tan PQ, Xu FY. Pulmonary function and artery blood analysis of diabetes mellitus [in Chinese]. Zhonghua Nei Ke Za Zhi. 1990;29(12):736-738, 766.
56. Zamarrón C, Del Campo F, Paredes C, et al. Pulmonary diffusion of carbon monoxide in 2 clinical situations: bronchial asthma and diabetes mellitus [in Spanish]. Med Interna. 2001;18(5):237-242.
57. Vandevoorde J, Verbanck S, Gijssels L, et al. Early detection of COPD:a case finding study in general practice. Respir Med. 2007;101(3):525-530.
58. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):549-555.
59. Lange P, Parner J, Schnohr P, Jensen G. Copenhagen City Heart Study:longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J. 2002;20(6):1406-1412.
60. Litonjua AA, Lazarus R, Sparrow D, Demolles D, Weiss ST. Lung function in type 2 diabetes:the Normative Aging Study. Respir Med. 2005;99(12):1583-1590. (Pubitemid 41683939)
61. Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelium and capillaries:quantitative changes with aging and in diabetes mellitus. Am Rev Respir Dis. 1979;120(5):973-983.
62. Mehdi U, Toto RD. Anemia, diabetes, and chronic kidney disease. Diabetes Care. 2009;32(7):1320-1326.
63. Antonelli Incalzi R, Fuso L, Giordano A, et al. Neuroadrenergic denervation of the lung in type I diabetes mellitus complicated by autonomic neuropathy. Chest. 2002;121(2):443-451.
64. Guvener N, Tutuncu NB, Akcay, Eyuboglu F, Gokcel A. Alveolar gas exchange in patients with type 2 diabetes mellitus. Endocr J. 2003;50(6):663-667. (Pubitemid 38139948)
65. Engström G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med. 2003;253(5):574-581.
66. Eriksson KF, Lindgärde F. Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia. 1996;39(5):573-579. (Pubitemid 26135460)
67. Engström G, Janzon L. Risk of developing diabetes is inversely related to lung function:a population-based cohort study. Diabet Med. 2002;19(2):167-170.
68. Ford ES, Mannino DM;National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care. 2004;27(12):2966-2970.
69. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes:the Atherosclerosis Risk in Communities study. Diabetes Care. 2005;28(6):1472-1479.
70. Hancox RJ, Poulton R, Greene JM, McLachlan CR, Pearce MS, Sears MR. Associations between birth weight, early childhood weight gain and adult lung function. Thorax. 2009;64(3):228-232.
71. Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of type 2 diabetes:a systematic review. JAMA. 2008;300(24):2886-2897.
72. Lee HM, Le TV, Lopez VA, Wong ND. Association of C-reactive protein with reduced forced vital capacity in a nonsmoking U.S. population with metabolic syndrome and diabetes. Diabetes Care. 2008;31(10):2000-2002.
73. Liu MC, Riese RJ, Van Gundy K, et al. Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes. Eur Respir J. 2008;32(1):180-188.
74. Geistanger A, Arends S, Berding C, et al; IFCC Working Group on Standardization of Hemoglobin A1c. Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden. Clin Chem. 2008;54(8):1379-1385.